ID   CDC5L_RAT               Reviewed;         802 AA.
AC   O08837;
DT   16-AUG-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 2.
DT   02-OCT-2024, entry version 172.
DE   RecName: Full=Cell division cycle 5-like protein;
DE   AltName: Full=Cdc5-like protein;
DE   AltName: Full=Pombe Cdc5-related protein;
GN   Name=Cdc5l; Synonyms=Pcdc5rp;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], SUBCELLULAR LOCATION, INDUCTION, AND
RP   DNA-BINDING.
RC   STRAIN=Noble;
RX   PubMed=11694351; DOI=10.1016/s0303-7207(01)00585-8;
RA   Johnson L.M., Too C.K.L.;
RT   "Prolactin, interleukin-2 and FGF-2 stimulate expression, nuclear
RT   distribution and DNA-binding of rat homolog of pombe Cdc5 in Nb2 T lymphoma
RT   cells.";
RL   Mol. Cell. Endocrinol. 184:151-161(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], INTERACTION WITH DAPK3, SUBUNIT, AND
RP   SUBCELLULAR LOCATION.
RC   TISSUE=Fibroblast;
RX   PubMed=11884640; DOI=10.1093/nar/30.6.1408;
RA   Engemann H., Heinzel V., Page G., Preuss U., Scheidtmann K.H.;
RT   "DAP-like kinase interacts with the rat homolog of Schizosaccharomyces
RT   pombe CDC5 protein, a factor involved in pre-mRNA splicing and required for
RT   G2/M phase transition.";
RL   Nucleic Acids Res. 30:1408-1417(2002).
RN   [3]
RP   PROTEIN SEQUENCE OF 34-40; 400-414; 467-473; 478-487 AND 689-694, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RA   Lubec G., Kang S.U., Lubec S.;
RL   Submitted (SEP-2007) to UniProtKB.
RN   [4]
RP   PHOSPHORYLATION, AND INTERACTION WITH PPP1R8.
RX   PubMed=10827081; DOI=10.1074/jbc.m001676200;
RA   Boudrez A., Beullens M., Groenen P.M.A., Van Eynde A., Vulsteke V.,
RA   Jagiello I., Murray M., Krainer A.R., Stalmans W., Bollen M.;
RT   "NIPP1-mediated interaction of protein phosphatase-1 with CDC5L, a
RT   regulator of pre-mRNA splicing and mitotic entry.";
RL   J. Biol. Chem. 275:25411-25417(2000).
RN   [5]
RP   INTERACTION WITH PRPF19.
RX   PubMed=16352598; DOI=10.1074/jbc.m510881200;
RA   Urano Y., Iiduka M., Sugiyama A., Akiyama H., Uzawa K., Matsumoto G.,
RA   Kawasaki Y., Tashiro F.;
RT   "Involvement of the mouse Prp19 gene in neuronal/astroglial cell fate
RT   decisions.";
RL   J. Biol. Chem. 281:7498-7514(2006).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-377; THR-385 AND THR-396, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: DNA-binding protein involved in cell cycle control. May act
CC       as a transcription activator. Plays a role in pre-mRNA splicing as core
CC       component of precatalytic, catalytic and postcatalytic spliceosomal
CC       complexes. Component of the PRP19-CDC5L complex that forms an integral
CC       part of the spliceosome and is required for activating pre-mRNA
CC       splicing. The PRP19-CDC5L complex may also play a role in the response
CC       to DNA damage (DDR). As a component of the minor spliceosome, involved
CC       in the splicing of U12-type introns in pre-mRNAs.
CC       {ECO:0000250|UniProtKB:Q99459}.
CC   -!- SUBUNIT: Homodimer. Interacts with DAPK3 (PubMed:11884640). Component
CC       of the precatalytic, catalytic and postcatalytic spliceosome complexes
CC       (By similarity). Part of a spliceosomal 'core' complex consisting of
CC       CDC5L, PLRG1, SPF27, CCAP1, CCAP3 and CCAP6. Interacts with PLRG1,
CC       Lodestar/TTF2, and NIPP1/PPP1R8 (PubMed:10827081). Identified in the
CC       spliceosome C complex. Component of the minor spliceosome, which
CC       splices U12-type introns. Within this complex, interacts with SCNM1 (By
CC       similarity). Component of the PRP19-CDC5L splicing complex composed of
CC       a core complex comprising a homotetramer of PRPF19, CDC5L, PLRG1 and
CC       BCAS2, and at least three less stably associated proteins CTNNBL1,
CC       CWC15 and HSPA8. Interacts (via its C-terminus) directly in the complex
CC       with PRPF19 and BCAS2. Interacts (via its C-terminus) directly with
CC       PRGL1 (via its WD40 repeat domain); the interaction is required for
CC       mRNA splicing but not for spliceosome assembly. Also interacts with
CC       CTNNBL1. Interacts with PRPF19 (via N-terminus) (PubMed:16352598).
CC       Interacts with USB1 (By similarity). {ECO:0000250|UniProtKB:Q99459,
CC       ECO:0000269|PubMed:10827081, ECO:0000269|PubMed:11884640,
CC       ECO:0000269|PubMed:16352598}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00625,
CC       ECO:0000269|PubMed:11694351, ECO:0000269|PubMed:11884640}. Nucleus
CC       speckle {ECO:0000255|PROSITE-ProRule:PRU00625}. Cytoplasm
CC       {ECO:0000269|PubMed:11694351}. Note=May shuttle between cytoplasm and
CC       nucleus. {ECO:0000303|PubMed:11694351}.
CC   -!- INDUCTION: By prolactin, IL-2 and FGF-2 in prolactin-dependent lymphoid
CC       cells (at protein level). {ECO:0000269|PubMed:11694351}.
CC   -!- PTM: Phosphorylated on serine and threonine residues. Phosphorylation
CC       on Thr-411 and Thr-438 is required for CDC5L-mediated mRNA splicing.
CC       Has no effect on subcellular location nor on homodimerization.
CC       Phosphorylated in vitro by CDK2 (By similarity). Phosphorylation
CC       enhances interaction with PPP1R8. {ECO:0000250,
CC       ECO:0000269|PubMed:10827081}.
CC   -!- SIMILARITY: Belongs to the CEF1 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF000578; AAD05365.2; -; mRNA.
DR   RefSeq; NP_445979.1; NM_053527.1.
DR   AlphaFoldDB; O08837; -.
DR   BMRB; O08837; -.
DR   SMR; O08837; -.
DR   IntAct; O08837; 4.
DR   STRING; 10116.ENSRNOP00000027264; -.
DR   iPTMnet; O08837; -.
DR   PhosphoSitePlus; O08837; -.
DR   jPOST; O08837; -.
DR   PaxDb; 10116-ENSRNOP00000027264; -.
DR   Ensembl; ENSRNOT00000027264.5; ENSRNOP00000027264.4; ENSRNOG00000019975.6.
DR   Ensembl; ENSRNOT00055012680; ENSRNOP00055010097; ENSRNOG00055007576.
DR   Ensembl; ENSRNOT00060035789; ENSRNOP00060029449; ENSRNOG00060020516.
DR   Ensembl; ENSRNOT00065045110; ENSRNOP00065036992; ENSRNOG00065026122.
DR   GeneID; 85434; -.
DR   KEGG; rno:85434; -.
DR   UCSC; RGD:70892; rat.
DR   AGR; RGD:70892; -.
DR   CTD; 988; -.
DR   RGD; 70892; Cdc5l.
DR   eggNOG; KOG0050; Eukaryota.
DR   GeneTree; ENSGT00550000074922; -.
DR   HOGENOM; CLU_009082_0_0_1; -.
DR   InParanoid; O08837; -.
DR   OrthoDB; 131128at2759; -.
DR   PhylomeDB; O08837; -.
DR   TreeFam; TF101061; -.
DR   Reactome; R-RNO-72163; mRNA Splicing - Major Pathway.
DR   PRO; PR:O08837; -.
DR   Proteomes; UP000002494; Chromosome 9.
DR   Bgee; ENSRNOG00000019975; Expressed in heart and 19 other cell types or tissues.
DR   ExpressionAtlas; O08837; baseline and differential.
DR   GO; GO:0071013; C:catalytic step 2 spliceosome; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005662; C:DNA replication factor A complex; ISO:RGD.
DR   GO; GO:0016607; C:nuclear speck; IDA:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:RGD.
DR   GO; GO:0032993; C:protein-DNA complex; IDA:RGD.
DR   GO; GO:0000974; C:Prp19 complex; ISS:UniProtKB.
DR   GO; GO:0005681; C:spliceosomal complex; ISO:RGD.
DR   GO; GO:0071007; C:U2-type catalytic step 2 spliceosome; ISS:UniProtKB.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0043522; F:leucine zipper domain binding; IPI:RGD.
DR   GO; GO:0019901; F:protein kinase binding; IPI:RGD.
DR   GO; GO:0008157; F:protein phosphatase 1 binding; IPI:RGD.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0001222; F:transcription corepressor binding; IPI:RGD.
DR   GO; GO:0071987; F:WD40-repeat domain binding; ISS:UniProtKB.
DR   GO; GO:0044344; P:cellular response to fibroblast growth factor stimulus; IEP:RGD.
DR   GO; GO:0071352; P:cellular response to interleukin-2; IEP:RGD.
DR   GO; GO:1990090; P:cellular response to nerve growth factor stimulus; IDA:RGD.
DR   GO; GO:1990646; P:cellular response to prolactin; IEP:RGD.
DR   GO; GO:1904568; P:cellular response to wortmannin; IDA:RGD.
DR   GO; GO:0000077; P:DNA damage checkpoint signaling; ISS:UniProtKB.
DR   GO; GO:0006281; P:DNA repair; IEA:UniProtKB-KW.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:RGD.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; TAS:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   CDD; cd00167; SANT; 1.
DR   CDD; cd11659; SANT_CDC5_II; 1.
DR   Gene3D; 1.10.10.60; Homeodomain-like; 2.
DR   InterPro; IPR047242; CDC5L/Cef1.
DR   InterPro; IPR021786; Cdc5p/Cef1_C.
DR   InterPro; IPR009057; Homeodomain-like_sf.
DR   InterPro; IPR017930; Myb_dom.
DR   InterPro; IPR001005; SANT/Myb.
DR   InterPro; IPR047240; SANT_CDC5L_II.
DR   PANTHER; PTHR45885; CELL DIVISION CYCLE 5-LIKE PROTEIN; 1.
DR   PANTHER; PTHR45885:SF1; CELL DIVISION CYCLE 5-LIKE PROTEIN; 1.
DR   Pfam; PF11831; Myb_Cef; 1.
DR   Pfam; PF13921; Myb_DNA-bind_6; 1.
DR   SMART; SM00717; SANT; 2.
DR   SUPFAM; SSF46689; Homeodomain-like; 2.
DR   PROSITE; PS51294; HTH_MYB; 2.
PE   1: Evidence at protein level;
KW   Activator; Cell cycle; Coiled coil; Cytoplasm; Direct protein sequencing;
KW   DNA damage; DNA repair; DNA-binding; Isopeptide bond; mRNA processing;
KW   mRNA splicing; Nucleus; Phosphoprotein; Reference proteome; Repeat;
KW   RNA-binding; Spliceosome; Transcription; Transcription regulation;
KW   Ubl conjugation.
FT   CHAIN           1..802
FT                   /note="Cell division cycle 5-like protein"
FT                   /id="PRO_0000197093"
FT   DOMAIN          1..56
FT                   /note="HTH myb-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00625"
FT   DOMAIN          57..108
FT                   /note="HTH myb-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00625"
FT   DNA_BIND        31..54
FT                   /note="H-T-H motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00625"
FT   DNA_BIND        82..104
FT                   /note="H-T-H motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00625"
FT   REGION          108..143
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          200..206
FT                   /note="Required for interaction with CTNNBL1"
FT                   /evidence="ECO:0000250|UniProtKB:Q99459"
FT   REGION          246..278
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          260..606
FT                   /note="Interaction with PPP1R8"
FT                   /evidence="ECO:0000250|UniProtKB:Q99459"
FT   REGION          408..460
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          501..659
FT                   /note="Interaction with DAPK3"
FT                   /evidence="ECO:0000269|PubMed:11884640"
FT   REGION          706..800
FT                   /note="Interaction with PLRG1"
FT                   /evidence="ECO:0000250|UniProtKB:Q99459"
FT   COILED          146..192
FT                   /evidence="ECO:0000255"
FT   COILED          676..701
FT                   /evidence="ECO:0000255"
FT   COILED          761..801
FT                   /evidence="ECO:0000255"
FT   MOTIF           165..271
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        108..142
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        246..261
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        408..437
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         227
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99459"
FT   MOD_RES         303
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99459"
FT   MOD_RES         358
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99459"
FT   MOD_RES         377
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         385
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         396
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         404
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99459"
FT   MOD_RES         411
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99459"
FT   MOD_RES         415
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99459"
FT   MOD_RES         417
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99459"
FT   MOD_RES         424
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99459"
FT   MOD_RES         430
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99459"
FT   MOD_RES         438
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99459"
FT   MOD_RES         442
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99459"
FT   CROSSLNK        135
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q99459"
FT   CROSSLNK        219
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q99459"
FT   CROSSLNK        487
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q99459"
SQ   SEQUENCE   802 AA;  92218 MW;  3795F3D37E10FCC8 CRC64;
     MPRIMIKGGV WRNTEDEILK AAVMKYGKNQ WSRIASLLHR KSAKQCKARW YEWLDPSIKK
     TEWSREEEEK LLHLAKLMPT QWRTIAPIIG RTAAQCLEHY EFLLDKTAQR DNEEETTDDP
     RKLKPGEIDP NPETKPARPD PIDMDEDELE MLSEARARLA NTQGKKAKRK AREKQLEEAR
     RLAALQKRRE LRAAGIEIQK KRKKKRGVDY NAEIPFEKKP ALGFYDTSEE NYQALDADFR
     KLRQQDLDGE LRSEKEGRDR KKDKQHLKRK KESDLPSAIL QTSGVSEFTK KRSKLVLPAP
     QISDAELQEV VKVGQASEVA RQTAEESGIT NSASSTLLSE YNVTNNSIAL RTPRTPASQD
     RILQEAQNLM ALTNVDTPLK GGLNTPLHES DFSGVTPQRQ VVQTPNTVLS TPFRTPSNGA
     EGLTPRSGTT PKPVTNATPG RTPLRDKLNI NPEDGMADYS DPSYVKQMER ESREHLRLGL
     LGLPAPKNDF EIVLPENAEK ELEEREMDDT YIEDAADVDA RKQAIRDAER VKEMKRMHKA
     VQKDLPRPSE VNETILRPLN VEPPLTDLQK SEELIKKEMI TMLHYDLLHH PYEPSGNKKG
     KNVGFATNNS EHITYLEHSP YEKFSKEDLK KAQDVLVQEM EVVKQGMSHG ELSSEAYNQV
     WEECYSQVLY LPAQSRYTRA NLASKKDRIE SLEKRLEINR GHMTTEAKRA AKMEKKMKIL
     LGGYQSRAMG LLKQLNDLWD QIEQAHLELR TFEELKKHED SAIPRRLECL KEDVQRQQER
     EKELQQRYAD LLMEKETLQA KF
//
